The telehealth provider Hims & Hers Health has launched an aggressive dual acquisition strategy, signaling a major international push. The company's clea ...

Shares of telehealth provider Hims & Hers were up more than 5% Thursday morning after the company said it started serving customers in Canada, a sign of its plan to capitalize on international demand ...

In a Dec. 2 decision, the Delhi High Court dismissed Novo Nordisk's application to block production of semaglutide--the key ingredient in Ozempic and Wegovy--allowing the Indian drugmaker to make the ...

Weight loss drugs may still help to fight against Alzheimer’s disease, despite a study by the manufacturer of Ozempic showing ...

Delhi HC permits Dr Reddy's to export generics of Novo Nordisk's semaglutide, rejecting patent claims and addressing evergreening concerns.

Anyone can book a hotel room for the holidays, but pick a specialty themed suite at one of these six hotels around the ...

One of largest U.S. telehealth providers expects to ride wave of exploding demand for weight-loss drug semaglutide when it ...

Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving ...

According to JM Financial, the decision is a positive development for both Dr Reddy's and OneSource as it allows continuous manufacturing and the accumulation of inventory. This stock can later be dep ...

Feldstein Family Law Group, P.C. has released a new episode of Ask Andrew, the firm's monthly live Q&A program hosted by founder Andrew Feldstein.

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open ...